Cited by 456Mast cells and histamineFood Allergy and Anaphylaxis ResearchDrug-Induced Adverse Reactions

Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.

Open access
Schwartz, L B, Yunginger, J W, Miller, J, Bokhari, R, Dull, D·1989·Journal of Clinical Investigation

Abstract

Tryptase, a neutral protease of human mast cells, is a potentially important indicator of mast cell involvement in various clinical conditions. The current study examined the time course of appearance and disappearance of tryptase in the circulation after an anaphylactic event and the stability of both endogenous and exogenous tryptase in terms of freeze-thawing and temperature. The peak level of tryptase after an experimentally induced systemic anaphylactic reaction occurred 1-2 h after the initiating bee sting in each of three subjects, in contrast to histamine levels which peaked at 5-10 min. In some cases elevated levels of tryptase may not be detected during the initial 15-30 min. Tryptase levels then declined under apparent first order kinetics with a t1/2 of approximately 2h. Similar disappearance kinetics were observed for two subjects presenting in the emergency room with immediate type reactions, one with severe asthma after indomethacin ingestion, the other with systemic anaphylaxis after a bee sting. Histamine levels declined rapidly and were back to baseline by 15-60 min. Measured levels of tryptase in serum or plasma were not diminished by up to four freeze-thaw cycles. Incubation of serum samples taken from subjects with elevated levels of tryptase at 22 and 37 degrees C indicated that greater than 50% of endogenous tryptase was still detected after 4 d. Purified tryptase added to serum or plasma and incubated as above was less stable: approximately 50% of exogenous tryptase in serum and approximately 15% in plasma was detected after 2d of incubation. Therefore, optimally samples should be stored frozen, but even those stored at room temperature for up to 4 d should be satisfactory. The best time to obtain samples for tryptase determinations is 1-2 h after the precipitating event, but depending on the magnitude of the initial response elevated levels of tryptase may be present in the circulation for several hours.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci114051

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The most specific and reliable indicator of systemic mast cell activation is a transient, event-related, substantial rise in serum tryptase above the patient's own baseline.

    “the most specific and reliable marker of systemic MC activation is an acute and substantial event-related (transient) increase in the serum tryptase level over the individual’s baseline value.”

    From Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome (2019) · cites this paper as [16]

    The Introduction says tryptase selectively indicates mast-cell activation, and the Results show an event-related rise followed by a decline after venom challenge. But the paper does not establish that a substantial rise in serum tryptase over an individual’s own baseline is the most specific and reliable marker; its before-and-after challenge measurements used plasma, and its Methods describe fixed ranges for elevated levels. No page numbers are available in our copy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Although prior literature and specialized-center experience made tryptase the biomarker of choice for defining anaphylaxis and MCAS, no diagnostic threshold existed.

    “although it was clear that tryptase is the biomarker of choice to define anaphylaxis and thus MCAS based on previous literature data and experience in specialized centers [12–18], a diagnostic threshold was missing.”

    From Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome (2019) · cites this paper as [16]

    The Introduction and Discussion describe circulating tryptase as a useful, relatively selective indicator of mast-cell activation and report its clinical use in suspected anaphylaxis. The paper does not discuss MCAS or establish tryptase as its biomarker of choice. Its Methods give ranges for normal and elevated tryptase, so it does not support an unqualified claim that no threshold existed, although it does not set out a diagnostic threshold for MCAS. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Tryptase has repeatedly been described as the most specific and reliable biomarker of severe systemic mast cell activation in daily practice.

    “tryptase has been repeatedly described as the most specific and reliable biomarker of severe systemic MC activation in daily practice [12–18].”

    From Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome (2019) · cites this paper as [16]

    The Introduction (page not provided) says tryptase selectively indicates mast-cell activation and is more clinically practical to measure than histamine; the Discussion describes cases where testing helped confirm anaphylaxis. The paper does not establish that tryptase is the most specific and reliable biomarker in daily practice, and it notes that elevations may be missed early after a reaction. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • In the work-up of anaphylaxis, BST levels raise significantly after the episode due to considerable release by MC and are expected to return to baseline at least after 24 h.

    “In the work-up of anaphylaxis, BST levels raise significantly after the episode due to the considerable release by MC and is expected to turn to the baseline value at least after 24 h (28, 29).”

    From Defining “Normal” basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis (2025) · cites this paper as [29]

    The Results report elevated tryptase after anaphylaxis, and the Introduction identifies tryptase as a mast-cell granule protein. The Discussion says levels decline with an approximately 2-hour half-life and may remain elevated for several hours, but it does not establish that they return to an individual's baseline at 24 hours. The indexed passages provide no page numbers. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • During and soon after a severe anaphylactic event, serum tryptase rises substantially above the individual's baseline.

    “during and shortly after a severe anaphylactic event where MC release large amounts of tryptase, the serum tryptase level increases substantially over the individual’s baseline (Fig. 1) [12–17].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schwartz, L. B., Yunginger, J. W., Miller, J., Bokhari, R., & Dull, D.
Affiliations
  • Virginia Commonwealth University Medical Center (US)
  • Mayo Clinic (US)
Venue
Journal of Clinical Investigation
Published
1989-05-01
Volume
83
Issue
5
Pages
1551-1555
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2024275029
Cited by
456
References
18
Citations by year
2026: 4 · 2025: 13 · 2024: 6 · 2023: 9 · 2022: 6 · 2021: 14 · 2020: 6 · 2019: 16 · 2018: 8 · 2017: 10 · 2016: 11 · 2015: 12 · 2014: 20 · 2013: 9 · 2012: 4
FWCI
6.41
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Allergy and Infectious Diseases (AI20487, AI-72621)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
  • Health Sciences › Medicine › Pharmacology › Drug-Induced Adverse Reactions
Keywords
tryptase, mast cells, anaphylaxis, bee stings, histamine, freeze-thaw cycles, sample storage, immediate hypersensitivity, serum biomarkers
MeSH terms
Adult, Anaphylaxis, Body Temperature, Child, Preschool, Female, Freezing, Histamine Release, Humans, Kinetics, Mast Cells, Peptide Hydrolases, Temperature

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review